Outcomes based on histopathologic response to preoperative chemotherapy in children with bilateral Wilms tumor: A prospective study (COG AREN0534)
dc.contributor.author | Chintagumpala, Murali M. | |
dc.contributor.author | Perlman, Elizabeth J. | |
dc.contributor.author | Tornwall, Brett | |
dc.contributor.author | Chi, Yueh-Yun | |
dc.contributor.author | Kim, Yeonil | |
dc.contributor.author | Hoffer, Fredric A. | |
dc.contributor.author | Kalapurakal, John A. | |
dc.contributor.author | Warwick, Anne B. | |
dc.contributor.author | Shamberger, Robert C. | |
dc.contributor.author | Khanna, Geetika | |
dc.contributor.author | Hamilton, Thomas E. | |
dc.contributor.author | Gow, Kenneth W. | |
dc.contributor.author | Paulino, Arnold C. | |
dc.contributor.author | Gratias, Eric J. | |
dc.contributor.author | Mullen, Elizabeth A. | |
dc.contributor.author | Geller, James I. | |
dc.contributor.author | Fernandez, Conrad V. | |
dc.contributor.author | Ritchey, Michael L. | |
dc.contributor.author | Grundy, Paul E. | |
dc.contributor.author | Dome, Jeffrey S. | |
dc.contributor.author | Ehrlich, Peter F. | |
dc.date.accessioned | 2022-07-05T21:03:21Z | |
dc.date.available | 2023-08-05 17:03:20 | en |
dc.date.available | 2022-07-05T21:03:21Z | |
dc.date.issued | 2022-07-01 | |
dc.identifier.citation | Chintagumpala, Murali M.; Perlman, Elizabeth J.; Tornwall, Brett; Chi, Yueh-Yun ; Kim, Yeonil; Hoffer, Fredric A.; Kalapurakal, John A.; Warwick, Anne B.; Shamberger, Robert C.; Khanna, Geetika; Hamilton, Thomas E.; Gow, Kenneth W.; Paulino, Arnold C.; Gratias, Eric J.; Mullen, Elizabeth A.; Geller, James I.; Fernandez, Conrad V.; Ritchey, Michael L.; Grundy, Paul E.; Dome, Jeffrey S.; Ehrlich, Peter F. (2022). "Outcomes based on histopathologic response to preoperative chemotherapy in children with bilateral Wilms tumor: A prospective study (COG AREN0534)." Cancer (13): 2493-2503. | |
dc.identifier.issn | 0008-543X | |
dc.identifier.issn | 1097-0142 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/173018 | |
dc.publisher | Wiley Periodicals, Inc. | |
dc.publisher | National Wilms’ Tumor Study Group | |
dc.subject.other | blastemal-type Wilms | |
dc.subject.other | bilateral Wilms tumors | |
dc.subject.other | risk stratification | |
dc.subject.other | preoperative chemotherapy in Wilms tumors | |
dc.subject.other | histopathologic response | |
dc.title | Outcomes based on histopathologic response to preoperative chemotherapy in children with bilateral Wilms tumor: A prospective study (COG AREN0534) | |
dc.type | Article | |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Public Health | |
dc.subject.hlbsecondlevel | Oncology and Hematology | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.description.peerreviewed | Peer Reviewed | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/173018/1/cncr34219.pdf | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/173018/2/cncr34219_am.pdf | |
dc.identifier.doi | 10.1002/cncr.34219 | |
dc.identifier.source | Cancer | |
dc.identifier.citedreference | Indolfi P, Jenkner A, Terenziani M, et al. Synchronous bilateral Wilms tumor: a report from the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP). Cancer. 2013; 119: 1586 - 1592. | |
dc.identifier.citedreference | Sudour H, Audry G, Schleimacher G, Patte C, Dussart S, Bergeron C. Bilateral Wilms tumors (WT) treated with the SIOP 93 protocol in France: epidemiological survey and patient outcome. Pediatr Blood Cancer. 2012; 59: 57 - 61. | |
dc.identifier.citedreference | Daw NC, Chi YY, Kalapurakal JA, et al. Activity of vincristine and irinotecan in diffuse anaplastic Wilms tumor and therapy outcomes of stage II to IV disease: results of the Children’s Oncology Group AREN0321 Study. J Clin Oncol. 2020; 38: 1558 - 1568. | |
dc.identifier.citedreference | Fernandez CV, Mullen EA, Chi YY, et al. Outcome and prognostic factors in stage III favorable-histology Wilms tumor: a report from the Children’s Oncology Group Study AREN0532. J Clin Oncol. 2018; 36: 254 - 261. | |
dc.identifier.citedreference | Verschuur AC, Vujanic GM, van Tinternen H, Pritchard Jones K, de Kraker J, Sandstedt B. Stromal and epithelial predominant Wilms tumours have an excellent outcome: the SIOP 93-01 experience. Pediatr Blood Cancer. 2010; 55: 233 - 238. | |
dc.identifier.citedreference | Vujanic GM, D’Hooghe E, Graf N, et al. Prognostic significance of histopathological response to preoperative chemotherapy in unilateral Wilms’ tumor: an analysis of 899 patients treated on the SIOP WT 2001 protocol in the UK-CCLG and GPOH studies. Int J Cancer. 2021; 149: 1332 - 1340. | |
dc.identifier.citedreference | Reinhard H, Semler O, Burger D, et al. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms tumor. Klin Padiatr. 2004; 216: 132 - 140. | |
dc.identifier.citedreference | Weirich A, Ludwig R, Graf N, et al. Survival in nephroblastoma treated according to the trial and study SIOP-9/GPOH with respect to relapse and morbidity. Ann Oncol. 2004; 15: 808 - 820. | |
dc.identifier.citedreference | van den Heuvel-Eibrink MM, van Tinternen H, Bergeron C, et al. Outcome of localised blastemal-type Wilms tumour patients treated according to intensified treatment in the SIOP WT 2001 protocol, a report of the SIOP Renal Tumour Study Group (SIOP-RTSG). Eur J Cancer. 2015; 51: 498 - 506. | |
dc.identifier.citedreference | Peto R, Peto J. Asymptotically efficient rank invariant test procedures. J R Stat Soc A. 1972; 135: 185 - 207. | |
dc.identifier.citedreference | Dome JS, Perlman EJ, Graf N. Risk stratification for Wilms tumor: current approach and future directions. Am Soc Clin Oncol Educ Book. 2014; 34: 215 - 223. | |
dc.identifier.citedreference | Ehrlich P, Chi YY, Chintagumpala MM, et al. Results of the first prospective multi-institutional treatment study in children with bilateral Wilms tumor (AREN0534): a report from the Children’s Oncology Group. Ann Surg. 2017; 266: 470 - 478. | |
dc.identifier.citedreference | Shamberger RC, Guthrie KA, Ritchey ML, et al. Surgery-related factors and local recurrence of Wilms tumor in National Wilms Tumor Study 4. Ann Surg. 1999; 229: 292 - 297. | |
dc.identifier.citedreference | Hamilton TE, Ritchey ML, Haase GM, et al. The management of synchronous bilateral Wilms tumor: a report from the National Wilms Tumor Study Group. Ann Surg. 2011; 253: 1004 - 1010. | |
dc.identifier.citedreference | Hamilton TE, Green DM, Perlman EJ, et al. Bilateral Wilms’ tumor with anaplasia: lessons from the National Wilms’ Tumor Study. J Pediatr Surg. 2006; 41: 1641 - 1644. | |
dc.identifier.citedreference | Shamberger RC, Haase GM, Argani P, et al. Bilateral Wilms’ tumors with progressive or nonresponsive disease. J Pediatr Surg. 2006; 41: 652 - 657. | |
dc.identifier.citedreference | Dome JS, Cotton CA, Perlman EJ, et al. Treatment of anaplastic histology Wilms’ tumor: results from the fifth National Wilms’ Tumor Study. J Clin Oncol. 2006; 24: 2352 - 2358. | |
dc.identifier.citedreference | Grundy PE, Breslow NE, Li S, et al. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group. J Clin Oncol. 2005; 23: 7312 - 7321. | |
dc.identifier.citedreference | Grigoriev Y, Ou S, Breselow N, et al. National Wilms Tumor Study 5 Statistical Report. National Wilms’ Tumor Study Group; 2002. | |
dc.identifier.citedreference | Vujanic GM, Gessler M, Ooms AHAG, et al. The UMBRELLA SIOP-RTSG 2016 Wilms tumour pathology and molecular biology protocol. Nat Rev Urol. 2018; 15: 693 - 701. | |
dc.working.doi | NO | en |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.